Forte Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 08/14/2024 | 3.62 M | $1.95 M | 0.00% | 7.87% |
| PERCEPTIVE ADVISORS LLC | 08/16/2024 | 3.27 M | $1.75 M | 0.00% | 7.09% |
| BVF INC/IL | 08/14/2024 | 2.98 M | $1.60 M | 0.00% | 6.47% |
| CABLE CAR CAPITAL LLC | 08/14/2024 | 2.03 M | $1.09 M | 0.00% | 4.41% |
| FRED ALGER MANAGEMENT, LLC | 08/14/2024 | 1.84 M | $987.52 K | 0.00% | 3.99% |
| FARALLON CAPITAL MANAGEMENT LLC | 08/14/2024 | 1.81 M | $972.21 K | 0.00% | 3.93% |
| BML CAPITAL MANAGEMENT, LLC | 08/07/2024 | 1.76 M | $946.03 K | 0.00% | 3.82% |
| VANGUARD GROUP INC | 08/13/2024 | 665.23 K | $357.23 K | 0.00% | 1.44% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 346.29 K | $186.01 K | 0.83% | 0.75% |
| BLACKROCK INC. | 08/13/2024 | 174.86 K | $93.90 K | 0.00% | 0.38% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/13/2024 | 159.26 K | $85.52 K | -6.60% | 0.35% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 133.40 K | $71.64 K | 0.98% | 0.29% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 40.81 K | $21.92 K | -0.13% | 0.09% |
| STATE STREET CORP | 08/14/2024 | 37.56 K | $20.17 K | -9.84% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 34.34 K | $18.44 K | 100.00% | 0.07% |
| NORTHERN TRUST CORP | 08/14/2024 | 26.82 K | $14.40 K | -0.35% | 0.06% |
| UBS GROUP AG | 08/14/2024 | 24.31 K | $13.06 K | 73,566.67% | 0.05% |
| 09/05/2024 | 22.01 K | $15.77 K | 100.00% | 0.05% | |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 20.78 K | $11.16 K | 0.01% | 0.05% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 15.80 K | $8.48 K | 35.70% | 0.03% |
| GROUP ONE TRADING, L.P. | 08/14/2024 | 14.02 K | $7.53 K | -3.51% | 0.03% |
| ARIES WEALTH MANAGEMENT | 07/25/2024 | 13.00 K | $6.98 K | 0.00% | 0.03% |
| HSBC HOLDINGS PLC | 08/12/2024 | 10.75 K | $5.89 K | 0.00% | 0.02% |
| CITADEL ADVISORS LLC | 08/14/2024 | 8.10 K | $4.35 K | -71.31% | 0.02% |
| MORGAN STANLEY | 10/17/2024 | 3.80 K | $2.04 K | 282.70% | 0.01% |
| CITADEL ADVISORS LLC | 08/14/2024 | 3.10 K | $1.67 K | 210.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 08/13/2024 | 1.08 K | $582 | 0.00% | 0.00% |
| RUSSELL INVESTMENTS GROUP, LTD. | 08/08/2024 | 453 | $243 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 265 | $142 | 100.00% | 0.00% |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | 07/17/2024 | 193 | $112 | 0.00% | 0.00% |
| FMR LLC | 08/13/2024 | 128 | $69 | 100.00% | 0.00% |
| 02/27/2025 | 97 | $52 | 0.00% | 0.00% | |
| JPMORGAN CHASE & CO | 12/26/2024 | 17 | $9 | 0.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 3 | $2 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Forte Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 5 institutional investors and hedge funds held shares of Forte Biosciences, Inc.. The most heavily invested institutionals were:
BlackRock Inc.: 174,858
Cutler Group LLC / CA: 0
PARAMETRIC PORTFOLIO ASSOCIATES LLC: 68,467
Amalgamated Financial Corp.: 1,931
Marshall Wace North America L.P.: 0
41.38% of Forte Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 245.26 K shares in the last 24 months. This purchase volume represents approximately $1.67 M in transactions.